Skip to main content

Want a detailed portfolio tracker?

Hims & Hers Health (HIMS) Market Cap (2019 - 2026)

Hims & Hers Health (HIMS) market cap from Sep 13, 2019 to Jun 3, 2026. The current Hims & Hers Health (HIMS) market cap is $6.28B. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Market Cap

Hims & Hers Health (HIMS) Market Cap CAGR table

PeriodCAGR
1 Year TTM+37.17%
3 Years TTM+79.41%
5 Years TTM+65.41%
All Time TTM+37.43%

Annual Market Cap change of Hims & Hers Health (HIMS)

YearMarket CapChange
2026$6.28B-14.49%
2025$7.35B+40.32%
2024$5.24B+180.07%
2023$1.87B+42.16%
2022$1.32B+0.40%
2021$1.31B+151.98%
2020$520M-77.00%
2019$2.26BN/A

Comparison Hims & Hers Health (HIMS) market cap with competitors

Hims & Hers Health (HIMS) market cap is $6.28B.

TickerNameMarket CapUpside
TAKTakeda Pharmaceutical Company$50.47B+703.08%
HLNHaleon plc$41.58B+561.71%
TEVATeva- Pharmaceutical Industries Ltd$39.95B+535.72%
ZTSZoetis Inc - Class A$33.41B+431.62%
UTHRUnited Therapeutics Corp$24.06B+282.86%
VTRSViatris Inc$18.82B+199.50%
NBIXNeurocrine Biosciences Inc$15.68B+149.45%
ELANElanco Animal Health Inc$11.83B+88.25%
RGCRegencell Bioscience Holdings Ltd$11.72B+86.56%
RDYDr. Reddy`s Laboratories Ltd$11.34B+80.39%
LNTHLantheus Holdings Inc$6.45B+2.61%
ALKSAlkermes plc$6.34B+0.89%
LQDALiquidia Corp$5.48B-12.84%
INDVIndivior Plc$4.60B-26.78%
AMRXAmneal Pharmaceuticals Inc - Class A$4.04B-35.73%
KNSAKiniksa Pharmaceuticals International plc. - Class A$3.97B-36.88%
SUPNSupernus Pharmaceuticals Inc$2.71B-56.93%
HCMHUTCHMED (China) Ltd$2.50B-60.21%
PBHPrestige Consumer Healthcare Inc$2.34B-62.78%
BCRXBiocryst Pharmaceuticals Inc$2.32B-63.14%
DCPHDeciphera Pharmaceuticals Inc$2.24B-64.42%
AVDLAvadel Pharmaceuticals plc$2.10B-66.52%
BHCBausch Health Companies Inc$2.01B-68.03%
DVAXDynavax Technologies Corp$1.82B-71.05%
ANIPANI Pharmaceuticals Inc$1.71B-72.79%
AMLXAmylyx Pharmaceuticals Inc$1.56B-75.14%
PRGOPerrigo Company plc$1.54B-75.48%
PAHCPhibro Animal Health Corp - Class A$1.33B-78.78%
HROWHarrow Inc$1.28B-79.58%
ALVOAlvotech$1.14B-81.92%
COLLCollegium Pharmaceutical Inc$1.09B-82.63%
XERSXeris Biopharma Holdings Inc$1.08B-82.89%
CRONCronos Group Inc$1.02B-83.71%
EVOEvotec SE$1.02B-83.78%
PCRXPacira BioSciences Inc$945.00M-84.96%
ETONEton Pharmaceuticals Inc$886.46M-85.89%
AMPHAmphastar Pharmaceuticals Inc$852.56M-86.43%
ESPREsperion Therapeutics Inc$786.74M-87.48%
BIOABioAge Labs Inc$752.36M-88.03%
TLRYTilray Brands Inc$646.84M-89.71%
IRWDIronwood Pharmaceuticals Inc - Class A$610.72M-90.28%
AQSTAquestive Therapeutics Inc$497.14M-92.09%
KMDAKamada Ltd$471.05M-92.50%
EBSEmergent Biosolutions Inc$465.94M-92.59%
EOLSEvolus Inc$406.89M-93.53%
CGCCanopy Growth Corporation$394.06M-93.73%
ORGOOrganogenesis Holdings Inc - Class A$342.27M-94.55%
SIGASIGA Technologies Inc$339.25M-94.60%
AKBAAkebia Therapeutics Inc$275.94M-95.61%
TKNOAlpha Teknova Inc$214.44M-96.59%
ACBAurora Cannabis Inc$198.91M-96.83%
ANIKAnika Therapeutics Inc$197.82M-96.85%
LFCRLifecore Biomedical Inc$180.64M-97.13%
DERMJourney Medical Corp$163.56M-97.40%
ASRTAssertio Holdings Inc$150.88M-97.60%
OGIOrganiGram Holdings Inc$146.04M-97.68%
CRDLCardiol Therapeutics Inc - Class A$139.50M-97.78%
CPIXCumberland Pharmaceuticals Inc$87.80M-98.60%
CTORCitius Oncology Inc$82.65M-98.68%
DRRXDurect Corp$59.52M-99.05%
INCRINC Research Holdings Inc$50.85M-99.19%
IXHLIncannex Healthcare Ltd$44.47M-99.29%
SCYXScynexis Inc$43.49M-99.31%
ZYBTZhengye Biotechnology Holding Ltd$41.04M-99.35%
TLPHTalphera Inc$41.02M-99.35%
BTAIBioXcel Therapeutics Inc$35.47M-99.44%
CPHIChina Pharma Holdings Inc$30.50M-99.51%
RMTIRockwell Medical Inc$30.16M-99.52%
TXMDTherapeuticsMD Inc$24.42M-99.61%
AYTUAytu BioPharma Inc$23.72M-99.62%
EVOKEvoke Pharma Inc$18.95M-99.70%
BFRIBiofrontera Inc$10.19M-99.84%
CABRCaring Brands Inc$9.55M-99.85%
YCBDcbdMD Inc$8.03M-99.87%
BGMQilian International Holding Group Ltd - Class A$7.45M-99.88%
INMInMed Pharmaceuticals Inc$5.50M-99.91%
RDHLRedhill Biopharma Ltd$5.20M-99.92%
GELSGelteq Ltd$4.41M-99.93%
SNOASonoma Pharmaceuticals Inc$3.55M-99.94%
SHPHShuttle Pharmaceuticals Holdings Inc$2.89M-99.95%
AKANAkanda Corp$2.23M-99.96%
APUSApimeds Pharmaceuticals US Inc$1.82M-99.97%
SBFMSunshine Biopharma Inc$1.80M-99.97%
UPCUniverse Pharmaceuticals Inc$1.61M-99.97%
IMCCIM Cannabis Corp$1.58M-99.97%
PRFXPRF Technologies Ltd$1.12M-99.98%
SXTCChina SXT Pharmaceuticals Inc$1.00M-99.98%